Veritiv Valuation Overview

VRTV -- USA Stock  

USD 40.65  0.55  1.37%

Veritiv has current Real Value of $47.460499999999996 per share. The regular price of the company is $40.65. At this time the company appears to be under valued. Macroaxis measures value of Veritiv from inspecting the company fundamentals such as Operating Margin of 0.82%, Shares Outstanding of 15.84M and Return On Equity of (4.96)% as well as reviewing its technical indicators and Probability Of Bankruptcy. In general, we recommend to buy undervalued stocks and to dispose of overvalued stocks since at some point securities prices and their ongoing real values will draw towards each other.
Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
Veritiv Corporation Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
Veritiv Market Cap
Veritiv Corporation is rated below average in market capitalization category among related companies. Market capitalization of Wholesale industry is at this time estimated at about 23.68 Billion. Veritiv holds roughly 627.24 Million in market capitalization claiming about 2.65% of Wholesale industry.
Capitalization  Valuation  Total debt  Revenue  Workforce
 Time Horizon     30 Days    Login   to change
Veritiv Corporation is rated below average in price to earning category among related companies. It is rated below average in price to sales category among related companies .

Current Market Valuation

Veritiv Valuation Boundaries
Under Valued
July 19, 2018
40.65
Market Value
47.46
Real Value
Target Odds
  
51.36
Upside
Veritiv is not too risky asset. Calculation of real value of Veritiv is based on 1 month time horizon. Increasing Veritiv time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Also please take a look at World Market Map. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.